Evaluation of antifungal activity, mechanisms of action and toxicological profile of the synthetic amide 2-chloro- N -phenylacetamide
Authors:
- Elba dos Santos FerreiraEFElba dos Santos Ferreira
- Laísa Vilar CordeiroLCLaísa Vilar Cordeiro
- Hermes Diniz NetoHNHermes Diniz Neto
- Aleson Pereira de SousaAleson Pereira de Sousa
- Helivaldo Diógenes da Silva SouzaHSHelivaldo Diógenes da Silva Souza
- José Maria Barbosa-FilhoJBJosé Maria Barbosa-Filho
- Edeltrudes de Oliveira LimaELEdeltrudes de Oliveira Lima
- 20 February 2023
- journal article
- research article
- Published by Taylor & Francis in Drug and Chemical Toxicology
- Vol. 47 (2) , 191-202
Abstract
Aspergillus niger causes infections such as otitis and pulmonary aspergillosis in immunocompromised individuals. Treatment involves voriconazole or amphotericin B, and due to the increase in fungal resistance, the search for new compounds with antifungal activity has intensified. In the development of new drugs, cytotoxicity and genotoxicity assays are important, as they allow predicting possible damage that a molecule can cause, and in silico studies predict the pharmacokinetic properties. The aim of this study was to verify the antifungal activity and the mechanism of action of the synthetic amide 2-chloro-N-phenylacetamide against Aspergillus niger strains and toxicity. 2-Chloro-N-phenylacetamide showed antifungal activity against different strains of Aspergillus niger with minimum inhibitory concentrations between 32 and 256 μg/mL and minimum fungicides between 64 and 1024 μg/mL. The minimum inhibitory concentration of 2-chloro-N-phenylacetamide also inhibited conidia germination. When associated with amphotericin B or voriconazole, 2-chloro-N-phenylacetamide had antagonistic effects. Interaction with ergosterol in the plasma membrane is the probable mechanism of action.2-Chloro-N-phenylacetamide has favorable physicochemical parameters, good oral bioavailability and absorption in the gastrointestinal tract, crosses the blood-brain barrier and inhibits CYP1A2. At concentrations of 50 to 500 µg/mL, it has little hemolytic effect and a protective effect for type A and O red blood cells, and in the cells of the oral mucosa it promotes little genotoxic change. It is concluded that 2-chloro-N-phenylacetamide has promising antifungal potential, favorable pharmacokinetic profile for oral administration and low cytotoxic and genotoxic potential, being a promising candidate for in vivo toxicity studies.Keywords
Funding Information
- CAPES (Finance Code 001)
This publication has 51 references indexed in Scilit:
- In vitro evaluation of antibiotics' combinations for empirical therapy of suspected methicillin resistant Staphylococcus aureussevere respiratory infectionsBMC Infectious Diseases, 2007
- Antifungal Activity of Zuccagnia punctata Cav.: Evidence for the Mechanism of ActionPlanta Medica, 2007
- Eficiência terapêutica das formulações lipídicas de anfotericina BRevista Brasileira de Ciências Farmacêuticas, 2006
- Hsp90 Potentiates the Rapid Evolution of New Traits: Drug Resistance in Diverse FungiScience, 2005
- Hemolytic Effects of Sodium Selenite and Mercuric Chloride in Human BloodDrug and Chemical Toxicology, 2005
- Chronic bilateral otomycosis caused by Aspergillus nigerMycoses, 2004
- Mycological and histological investigations in humans with middle ear infections*Mycoses, 2003
- Molecular Properties That Influence the Oral Bioavailability of Drug CandidatesJournal of Medicinal Chemistry, 2002
- Khat (Catha edulis) consumption causes genotoxic effects in humansInternational Journal of Cancer, 2001
- Apoptosis Contributes to Amphotericin B- Induced NephrotoxicityAntimicrobial Agents and Chemotherapy, 2001